Molecular characterisation of a panel of human ovarian carcinoma xenografts

被引:17
|
作者
Codegoni, AM
Nicoletti, MI
Buraggi, G
Valoti, G
Giavazzi, R
D'Incalci, M
Landoni, F
Maneo, A
Broggini, M
机构
[1] Mario Negri Inst Pharmacol Res, I-20157 Milan, Italy
[2] Mario Negri Inst Pharmacol Res, I-24125 Bergamo, Italy
[3] Univ Milan, Osped San Gerardo, Monza, MI, Italy
关键词
ovarian cancer; xenografts; cell cycle proteins; DNA repair; drug resistance;
D O I
10.1016/S0959-8049(98)00075-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In a panel of 16 human ovarian tumours transplanted in nude mice, the expression of genes involved in cell cycle regulation and in response to drug treatment were characterised. In the 16 tumours analysed we could not detect overexpression of Erb-B2 oncogene while expression of MDR1 mRNA was not detected in 11/15 samples and was low in 4/15 tumours. Only three tumours had mutations in the p53 gene exons 5-8 and one of these mutations did not result in any amino acid alteration. The levels of mRNA for cyclins A, D1 and E were heterogeneous with some tumours expressing high levels and others not expressing them at all. The same was found for the cyclin dependent kinases (CDK) CDK2 and CDK4 and for CDK inhibitors P21/WAF1, p27/KIP1 and p16/CDKN2. Two genes belonging to the nucleotide excision repair, ERCC1 and ERCC3 were detectable in all the samples examined, as were the genes MGMT and MAG, also involved in DNA repair. The data indicate a heterogeneity in the expression of genes considered to be involved in the cellular responses to cytotoxic drug treatment and indicate the possibility of using these tumour models to test specifically molecules with a defined mechanism of action. (C) 1998 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1432 / 1438
页数:7
相关论文
共 50 条
  • [1] Prevention of Carboplatin-induced Resistance in Human Ovarian Tumor Xenografts by Selenite
    Caffrey, Paula B.
    Frenkel, Gerald D.
    ANTICANCER RESEARCH, 2013, 33 (10) : 4249 - 4254
  • [2] THE ESTABLISHMENT, CHARACTERIZATION AND CALIBRATION OF HUMAN OVARIAN-CARCINOMA XENOGRAFTS FOR THE EVALUATION OF NOVEL PLATINUM ANTICANCER DRUGS
    HARRAP, KR
    JONES, M
    SIRACKY, J
    POLLARD, LA
    KELLAND, LR
    ANNALS OF ONCOLOGY, 1990, 1 (01) : 65 - 76
  • [3] Development of a panel of 15 human ovarian cancer xenografts for drug screening and determination of the role of the glutathione detoxification system
    Kolfschoten, GM
    Pinedo, HM
    Scheffer, PG
    Schlüper, HMM
    Erkelens, CAM
    Boven, E
    GYNECOLOGIC ONCOLOGY, 2000, 76 (03) : 362 - 368
  • [4] Selenite Enhances and Prolongs the Efficacy of Cisplatin Treatment of Human Ovarian Tumor Xenografts
    Caffrey, Paula B.
    Frenkel, Gerald D.
    IN VIVO, 2012, 26 (04): : 549 - 552
  • [5] Drug resistance features and S-phase fraction as possible determinants for drug response in a panel of human ovarian cancer xenografts
    G M Kolfschoten
    T M Hulscher
    H M Pinedo
    E Boven
    British Journal of Cancer, 2000, 83 : 921 - 927
  • [6] Drug resistance features and S-phase fraction as possible determinants for drug response in a panel of human ovarian cancer xenografts
    Kolfschoten, GM
    Hulscher, TM
    Pinedo, HM
    Boven, E
    BRITISH JOURNAL OF CANCER, 2000, 83 (07) : 921 - 927
  • [7] Backbone Degradable N-(2-Hydroxypropyl)methacrylamide Copolymer Conjugates with Gemcitabine and Paclitaxel: Impact of Molecular Weight on Activity toward Human Ovarian Carcinoma Xenografts
    Yang, Jiyuan
    Zhang, Rui
    Pan, Huaizhong
    Li, Yuling
    Fang, Yixin
    Zhang, Libin
    Kopecek, Jindrich
    MOLECULAR PHARMACEUTICS, 2017, 14 (05) : 1384 - 1394
  • [8] Effects of SC-560 in Combination with Cisplatin or Taxol on Angiogenesis in Human Ovarian Cancer Xenografts
    Li, Wei
    Wan, Liang
    Zhai, Ling-Yun
    Wang, Jane
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2014, 15 (10) : 19265 - 19280
  • [9] The Molecular Pathogenesis of Hereditary Ovarian Carcinoma
    Norquist, Barbara M.
    Garcia, Rochelle L.
    Allison, Kimberly H.
    Jokinen, Chris H.
    Kernochan, Lauren E.
    Pizzi, Catherine C.
    Barrow, Bethany J.
    Goff, Barbara A.
    Swisher, Elizabeth M.
    CANCER, 2010, 116 (22) : 5261 - 5271
  • [10] Molecular correlates of platinum response in human high-grade serous ovarian cancer patient-derived xenografts
    Topp, Monique D.
    Hartley, Lynne
    Cook, Michele
    Heong, Valerie
    Boehm, Emma
    McShane, Lauren
    Pyman, Jan
    McNally, Orla
    Ananda, Sumitra
    Harrell, Marisol
    Etemadmoghadam, Dariush
    Galletta, Laura
    Alsop, Kathryn
    Mitchell, Gillian
    Fox, Stephen B.
    Kerr, Jeffrey B.
    Hutt, Karla J.
    Kaufmann, Scott H.
    Swisher, Elizabeth M.
    Bowtell, David D.
    Wakefield, Matthew J.
    Scott, Clare L.
    MOLECULAR ONCOLOGY, 2014, 8 (03) : 656 - 668